Medical Science Liaison (MSL) – Cardiometabolic

At Sobi, each person brings their unique talents to work as a team and make a difference. We are dedicated to developing and delivering innovative therapies to improve the lives of people who live with a rare disease. Our edge comes from our team of people and our commitment to patients.

The Cardiometabolic Medical Science Liaison (MSL) is a field-based scientific expert responsible for building trusted peer-to-peer relationships with healthcare professionals, researchers, and key opinion leaders across Australia.

Starting with a fresh canvas, this role offers an exciting opportunity to build something meaningful from the ground up—playing a critical role in establishing Specialty Care at Sobi in Australia and creating waves through scientific leadership, purposeful partnerships, and a clear focus on unmet patient needs. Operating within a pre-registration environment, the MSL will help shape Sobi’s cardiometabolic presence, with particular emphasis on severe hypertriglyceridaemia (sHTG), familial chylomicronaemia syndrome (FCS), hypertriglyceridaemia-associated acute pancreatitis, and related metabolic disorders. By engaging leading experts in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine, the MSL will advance disease understanding, identify unmet medical needs, and help lay the foundations for future launch readiness.

As the primary medical field representative, the MSL will serve as the scientific interface between Sobi and the external healthcare community, delivering high-quality scientific exchange, facilitating medical education, generating strategic insights, and developing long-term scientific partnerships that improve patient care and outcomes.

Key contributions include:

• Developing deep scientific expertise in cardiometabolic disease, rare lipid disorders, and related conditions
• Representing Sobi in supporting the quality use of medicines and favourable patient outcomes
• Building and strengthening a network of partnerships with KOLs in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine
• Delivering medical education initiatives and high-quality scientific exchange
• Contributing to strategic planning, medical field activities, and launch readiness
• Providing field support, medical insights, and evidence generation activities across Australia

This is more than a traditional MSL role—it is an opportunity to be part of a bigger picture and help build the future of Specialty Care at Sobi in Australia. Starting with a fresh canvas, you will have the freedom to bring ideas, take initiative, and contribute beyond the traditional MSL remit through strategic medical projects, scientific partnerships, and cross-functional collaboration, while maintaining clear medical independence and compliance boundaries. At its core, this field-based role provides non-promotional educational, scientific and research support for the Sobi cardiometabolic portfolio, building trusted professional relationships with leading opinion leaders in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine across Australia.

You will help shape and proactively drive the local medical plan, turning field insights into meaningful initiatives and bringing fresh thinking to unmet medical needs, in accordance with local laws and the Medicines Australia Code of Conduct. As a strong advocate for patients, you will increase awareness of medical and patient needs, deepen understanding of data gaps and potential ways to address them, and support timely access to therapies.

You will play a critical role in establishing Specialty Care at Sobi and strengthening its presence and scientific credibility within the Australian cardiometabolic community. This is your chance to help create waves through purposeful scientific leadership, contribute to something bigger than an individual territory, and see your ideas help shape a growing medical function. Working within a pre-registration environment, you will build the scientific foundation for future commercial activities and launch readiness, while keeping all medical engagement balanced, non-promotional, and patient-focused.

ESSENTIAL RESPONSIBILITIES

Including, but not limited to, the following:

Key Opinion Leader Engagement

• Develop and maintain strong scientific relationships with national, regional, and emerging key opinion leaders (KOLs) across Australia
• Create and execute strategic engagement plans for healthcare professionals and researchers in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine
• Identify and cultivate relationships with future scientific leaders, investigators, and centres of excellence
• Establish productive partnerships with professional societies, academic institutions, scientific networks, and healthcare organisations relevant to cardiometabolic disease
• Conduct territory-specific disease, pathway, and medical expert mapping
• Act as a trusted scientific partner through ongoing, compliant, peer-to-peer scientific exchange
• Ensure >75% of time is spent on HCP interactions, HCP-focused activities, and/or in-field activities

Scientific Exchange and Medical Education

• Deliver high-quality, non-promotional scientific exchange with healthcare professionals and researchers
• Demonstrate and communicate clinical evidence, disease burden, unmet medical needs, and emerging scientific data relevant to cardiometabolic diseases
• Deliver peer-level presentations to HCPs and group meetings
• Educate and engage clinical specialists, academic faculty, medical researchers, hospital-based healthcare professionals, pharmacists, and allied health professionals
• Coordinate and support scientific meetings, educational workshops, advisory boards, congress activities, and symposia
• Represent Sobi at scientific congresses and major medical meetings
• Respond appropriately to unsolicited scientific and medical information requests in accordance with company policies and local regulations
• Ensure good reporting and interactions with Medical colleagues from other affiliates; share and receive best practices

Disease Area Leadership

• Develop and maintain deep scientific expertise in: severe hypertriglyceridaemia (sHTG), familial chylomicronaemia syndrome (FCS), hypertriglyceridaemia-associated acute pancreatitis, rare lipid disorders, and cardiometabolic disease
• Support disease awareness activities aimed at improving recognition, diagnosis, and management of patients living with rare lipid disorders
• Facilitate scientific discussions regarding disease burden, diagnostic pathways, referral patterns, and patient management challenges
• Maintain a comprehensive understanding of the evolving scientific and clinical landscape

Medical Insights and Landscape Development

• Gather and communicate insights from healthcare professionals regarding unmet medical needs, current treatment practices, diagnostic challenges, referral pathways, future research opportunities, and emerging scientific trends
• Identify and communicate key clinical and research insights from key opinion leaders to help formulate Sobi research and development, and business strategies
• Develop and maintain stakeholder maps and engagement plans
• Provide strategic field insights that support understanding of the Australian cardiometabolic landscape and future launch readiness activities

Research and Scientific Collaboration

• Identify investigators, treatment centres, and research networks with an interest in cardiometabolic and rare lipid diseases
• Respond and support unsolicited requests for investigator-initiated studies (IISs)
• Explore opportunities for scientific collaboration and evidence generation
• Support the identification of sites and investigators for future clinical research activities
• Facilitate scientific discussion regarding ongoing and emerging clinical research programmes
• Foster partnerships that contribute to advancing disease understanding and improving patient outcomes

Compliance and Reporting

• Conduct all activities in compliance with the Medicines Australia Code of Conduct, TGA requirements, pharmacovigilance obligations, and Sobi policies
• Ensure timely and accurate reporting regarding compliance, adverse events, safety documentation, and stakeholder interactions
• Ensure all external interactions remain scientific, balanced, and non-promotional, particularly within a pre-registration environment
• Demonstrating the highest standards of ethics, transparency, and patient focus in all activities
• Sobi Australia operates as an integrated cross-functional customer-facing team. This role is expected to fulfil the medical affairs components of that engagement and will provide appropriate support to cross-functional team members and projects

Essential

• Advanced scientific or healthcare degree (PharmD, PhD, MBBS, MSc, BPharm, or equivalent)
• Previous Medical Science Liaison, Field Medical Affairs, clinical research, or relevant scientific experience
• Ideally 2+ years of related pharma/biotech experience including at least 2 years as an MSL or in a medical field role
• Demonstrated understanding of the drug development and reimbursement process
• Strong scientific communication and presentation skills
• Demonstrated ability to establish and maintain relationships with external healthcare stakeholders
• Excellent interpersonal and stakeholder engagement capabilities
• Demonstrated competence in using AI-enabled and digital tools responsibly to improve productivity, analyse information, generate insights, and support high-quality medical affairs activities, while maintaining appropriate data privacy, confidentiality, compliance, and scientific oversight
• Proven ability to work autonomously in a field-based position, effectively prioritising activities, managing competing demands, making sound decisions, and remaining accountable for agreed objectives and timely execution
• Ability to travel extensively across Australia
• Australian Permanent Residency (or equivalent) is a requirement
• Full Australian driver's licence
• Completed Medicines Australia CEP program

Preferred

• Experience within lipidology, endocrinology, hepatology, gastroenterology, cardiology, or rare diseases
• Experience supporting pre-launch or pre-registration products
• Existing relationships within the Australian cardiometabolic community
• Understanding of the Australian healthcare environment and specialist referral pathways

Desired Capabilities

• Medical field competency and capabilities
• Ability to travel at least 50% of time
• Passion for science and teaching
• Adaptable mindset and problem-solving skills
• Excellent oral presentation and written communication skills
• Ability to analyse and effectively communicate scientific information; respond to inquiries and address needs of key stakeholders
• Ability to initiate and maintain relationship networks internally and externally throughout the medical community
• Demonstrated high level of personal integrity and emotional intelligence
• Understanding of the legal and regulatory environment
• Disease state knowledge in cardiometabolic disease, lipidology, or rare diseases is preferred
• Proven ability to work autonomously and independently with strong time management skills
• Ability to maintain command of a large body of scientific information across multiple products
• Strong working knowledge of the relevant codes of practice
• Proficient in MS Office applications and digital platforms
• Willingness to adapt to requirements outside normal working hours to collaborate with international colleagues

Critical Success Factors

• Establishment of meaningful scientific relationships with leading Australian experts in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine
• Delivery of high-quality scientific exchange and medical education activities
• Generation of actionable medical insights that enhance understanding of the Australian cardiometabolic landscape
• Identification of strategic scientific partnerships and future research opportunities
• Contribution to disease awareness and future launch readiness through strong external engagement
• Recognition as a trusted and credible scientific partner within the cardiometabolic community

The MSL is expected to show leadership in the adoption of the Sobi values:

• Care: Act in the best interests of patients, colleagues and company
• Ambition: Stay hungry and challenge the status quo
• Urgency: Act now because the patients can't wait and the market won't
• Ownership: Take decisions and act on them
• Partnership: Work together so we all win

Adherence to internal Sobi policies and the industry code of conduct is also required.